Latest filing published 03 Apr 2019 for IMV Inc. (formerly Immunovaccine Inc.), €7,220.
Albert James Scardino is a declared insider of IMV Inc. (formerly Immunovaccine Inc.), with filings sourced from SEDI. Between 2 May 2018 and 1 April 2019, the trades on record add up to 57 filings.
No open-market sale appears; the market trades are 53 purchases worth €220k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2019, the count stands at 12 purchases and no sales.
Half of the purchases are above €2,785 and half below. Across 53 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 3 April 2019, reports an open-market purchase of €7,220 in IMV Inc. (formerly Immunovaccine Inc.). Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 57 declarations